Nomura Holdings Inc Alnylam Pharmaceuticals, Inc. Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

A detailed history of Nomura Holdings Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 17,849 shares of ALNY stock, worth $4.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,849

Previous 6,426 177.76%

Holding current value

$4.44 Million

Previous $1.56 Million 214.48%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $2.67 Million - $3.28 Million	11,423 Added 177.76%	17,849 $4.91 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $920,910 - $1.59 Million	6,426 New	6,426 $1.56 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $1.99 Million - $2.29 Million	-10,779 Reduced 87.27%	1,572 $298,000
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $2.26 Million - $2.91 Million	12,351 New	12,351 $2.47 Million
Q3 2022 Nov 15, 2022	SELL	$138.54 - $232.0 $1.57 Million - $2.63 Million	-11,330 Reduced 64.95%	6,113 $1.23 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $2.1 Million - $2.95 Million	17,443 New	17,443 $2.58 Million
Q1 2022 May 18, 2022	SELL	$127.18 - $173.91 $2.85 Million - $3.9 Million	-22,403 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $3.3 Million - $4.33 Million	20,674 Added 1195.72%	22,403 $3.81 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $338,311 - $414,005	-1,993 Reduced 53.55%	1,729 $332,000
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $347,301 - $477,602	-2,700 Reduced 42.04%	3,722 $631,000
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $1.62 Million - $2.25 Million	-12,800 Reduced 66.59%	6,422 $907,000
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $1.69 Million - $2.02 Million	13,734 Added 250.26%	19,222 $2.5 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $628,321 - $768,210	5,488	5,488 $698,000

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Alnylam Pharmaceuticals, Inc. Transaction History